IntroductionBreast cancer treatment is an aggressive therapy that affects the patient's quality of life (QoL). This study aims to assess the impact of breast cancer treatment on the QoL of breast cancer patients undergoing treatment. MethodsThis cross-sectional study was conducted among breast cancer patients attending two tertiary care hospitals between August 2021 to December 2022. QoL of female patients above 18 years of age with a histopathological confirmation of Stage I-III breast cancer and an ECOG Performance Status between 0 and 1 was assessed using European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ C30) and Breast Cancer Specific Quality of Life Questionnaire (QLQ BR 23). Kruskal -Wallis and Mann Whitney U tests were used to assess the impact of treatment on QoL of breast cancer patients. Linear regression was used to identify predictors of QoL. ResultsA total of 428 respondents with a mean age of 48.67 years participated in the study. Mean score for Global Health Status was 59.87. High mean scores for functional scales were observed in cognitive functioning (79.17), followed by role functioning (72.04) and physical functioning (71.45). Among the symptom scales, high scores were noted for financial difficulty (67.60) followed by hair loss (54.52). QoL score of patients who underwent surgery was high (54.93) as compared to patients undergoing radiation (49.37) and chemotherapy (44.96). ConclusionThe overall QoL of women with breast cancer undergoing treatment was good. QoL of patients undergoing chemotherapy was the lowest, while patients who underwent surgery exhibited a better QoL.
Read full abstract